Acadia Pharmaceuticals
ACAD
ACAD
271 hedge funds and large institutions have $3.76B invested in Acadia Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 108 increasing their positions, 84 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
52% less capital invested
Capital invested by funds: $7.9B → $3.76B (-$4.15B)
57% less call options, than puts
Call options by funds: $43.4M | Put options by funds: $102M
67% less funds holding in top 10
Funds holding in top 10: 9 → 3 (-6)
Holders
271
Holding in Top 10
3
Calls
$43.4M
Puts
$102M
Top Buyers
| 1 | +$36.4M | |
| 2 | +$30.1M | |
| 3 | +$25.8M | |
| 4 |
HM
HealthCor Management
New York
|
+$23.2M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$16.5M |
Top Sellers
| 1 | -$59M | |
| 2 | -$45.4M | |
| 3 | -$35M | |
| 4 |
Jennison Associates
New York
|
-$31M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$29M |